Semaglutide
Glucagon-Like Peptide-1 (Glp-1) Analogues
Sold as Kayshild · WEGOVY · OZEMPIC · RYBELSUS · PLOSBRIO
- Drug class
- Glucagon-Like Peptide-1 (Glp-1) Analogues
- Availability
- See label
- Routes
- Subcutaneous, Oral
- Markets covered
- 3
- Products on record
- 195
Overview
Semaglutide is an active pharmaceutical ingredient in the Glucagon-Like Peptide-1 (Glp-1) Analogues group (A10BJ). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 147 | May 29, 2026 |
| CA Canada | Health Canada | 44 | May 27, 2026 |
| EU European Union | EMA | 4 | April 22, 2026 |
GBUnited Kingdom· MHRA
147 products
Uses
Rybelsus is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise • as monotherapy when metformin is considered inappropriate due to intolerance or contraindications.
• in combination with other medicinal products for the treatment of diabetes. 1.
How to take
CACanada· Health Canada
44 products
Uses
12 TABLE OF CONTENTS Sections or subsections that are not applicable at the time of authorization are not listed. RECENT MAJOR LABEL CHANGES ............................................................................ 2 TABLE OF CONTENTS..................................................................................................
2 PART I: HEALTH PROFESSIONAL INFORMATION .................................................... 4 1 INDICATIONS ...................................................................................................... 1 Pediatrics ...............................................................................................
2 Geriatrics ............................................................................................... 4 2 CONTRAINDICATIONS ....................................................................................... 4 3 SERIOUS WARNINGS AND PRECAUTIONS BOX ............................................
EUEuropean Union· EMA
4 products
Uses
Ozempic is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise • as monotherapy when metformin is considered inappropriate due to intolerance or contraindications • in addition to other medicinal products for the treatment of diabetes.
1.
How to take
Drug interactions
Known interactions involving Semaglutide. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PLGB046680420 · revised May 15, 2026
- [2]Health Canada (DPD) · 02497581 · revised April 1, 2026
- [3]European Medicines Agency · EMEA/H/C/004174 · revised April 22, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.